Human lymphoblastoid alpha-interferon for hairy cell leukemia. An update of the Italian Cooperative Group.
Massimo Federico(University of Modena and Reggio Emilia), Giovanni Rossi(Casa Sollievo della Sofferenza), Giovanni Capnist(Ospedale San Bortolo), G. Pagnucco, L Resegotti, Teodoro Chisesi(Ospedale Civile di Venezia), Antonio Frassoldati(Italian Oncology Group of Clinical Research), C. Guarnaccia(Ospedale Vincenzo Cervello), F Lauria, Teresa Lamparelli(Ospedale Policlinico San Martino)
PubMed
January 1, 1989
Cited by 1
Related Papers
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|339
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
|Cancer Research|2010|244
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
|Clinical Cancer Research|2019|240